Bridgeway Capital Management, LLC Praxis Precision Medicines, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.87 - $1.71 $87,000 - $171,000	100,000 Added 98.33%	201,700 $344,000
Q2 2023 Aug 14, 2023	SELL	$0.83 - $1.18 $44,903 - $63,838	-54,100 Reduced 34.72%	101,700 $116,000
Q1 2023 May 15, 2023	BUY	$0.8 - $4.98 $33,760 - $210,156	42,200 Added 37.15%	155,800 $126,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $284,000 - $4.31 Million	113,600 New	113,600 $258,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $2.88B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.